Brickell Biotech, Inc. announced that on May 27, 2020, George Abercrombie informed the company of his resignation from the company’s Board of Directors, effective immediately. In submitting his resignation, Mr. Abercrombie did not express any disagreement on any matter relating to the operations, policies or practices of the company. In connection with Mr. Abercrombie’s resignation, and in accordance with the company’s By-Laws, the Board of Directors of the company reduced the size of the Board from six members to five members.